Total Voting Rights
October 1, 2015 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company"), in
accordance with the Financial Conduct Authority's (the "FCA") Disclosure and
Transparency Rule 5.6.1R, notifies the market of the following:
As at September 30, 2015, the Company's issued ordinary share capital comprised
592,061,538 ordinary shares of 5 pence each with voting rights and a further
8,527,703 ordinary shares held in treasury.
Therefore the total number of voting rights in the Company is 592,061,538. This
is the figure which should be used by shareholders as the denominator for the
calculations by which they will determine if they are required to notify their
interest in, or a change to their interest in, the Company under the FCA's
Disclosure and Transparency Rules.
Oliver Strawbridge
Senior Assistant Company Secretary
For further information please contact:
Investor Relations
Matthew Osborne mattosborne@shire.com +1 781 482 9502
Sarah Elton-Farr seltonfarr@shire.com +44 1256 894157
NOTES TO EDITORS
Shire enables people with life-altering conditions to lead better lives.
Our strategy is to focus on developing and marketing innovative specialty
medicines to meet significant unmet patient needs.
We focus on providing treatments in Rare Diseases, Neuroscience,
Gastrointestinal and Internal Medicine and we are developing treatments for
symptomatic conditions treated by specialist physicians in other targeted
therapeutic areas, such as Ophthalmics.
http://www.shire.com/